Research Study
Meriva®, a master switch of inflammation also for eye disease

A new clinical study supports Meriva® as an adjunctive therapy of recurrent anterior uveitis, further confirming its role as a master switch of inflammation.
Research Study
A new clinical study supports Meriva® as an adjunctive therapy of recurrent anterior uveitis, further confirming its role as a master switch of inflammation.